Sapio HealthSapio Health
  • Today
  • Patients
  • Inbox
  • Calendar
Insight
  • Population
  • Quality (QOF)
System
  • Models
  • Data feeds
  • Settings
Practice trajectory
-26%
JD
Dr John Dolittle
Ashford Vale Medical Group
Patients/Carlos Hirano · SH-10402
← Practice Horizon

Carlos Hirano

55M · SH-10402APP
MASLD (moderate fibrosis risk) · Civil engineer
Next consult
No scheduled consult
Gray zone· p 0.66Trending worse
Trajectory headline
FIB-4 in the intermediate band with active metabolic drift. GLP-1 eligibility + hepatology referral should be discussed.
Model priority
Gray zone · pattern emerging
Biggest single change you could makeLifestyle programme → −88% (BMI)
AIME · trajectory-grounded

Drafted communications

Multi-LLM ensemble weighted by current physiological state — review before sending.

ReferralHepatology — MASLD with FIB-4 intermediate
To · Hepatology, Northgate Regional
Grounding
86%
55M with central obesity, prediabetes and dyslipidaemia. ALT/GGT persistently elevated over 18 months; FIB-4 2.1 on latest bloods. Continuous glucose monitor pattern consistent with worsening insulin resistance despite metformin. Forward Horizon-1 trajectory places him in moderate-to-advanced fibrosis territory within 3 years on current management. Requesting elastography and specialist opinion on GLP-1 eligibility under shared care.
Grounded on: ALT · FIB-4 · HbA1c · Triglycerides / hepatic-steatotic + metabolic
For demonstration purposes. Not a diagnostic tool.